Chapter 4 : Hospital-and Community-Acquired L Pneumonia: Two Faces of the Same Disease?

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Hospital-and Community-Acquired L Pneumonia: Two Faces of the Same Disease?, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815660/9781555813901_Chap04-1.gif /docserver/preview/fulltext/10.1128/9781555815660/9781555813901_Chap04-2.gif


This chapter compares the individual risk factors, clinical features, and mortality of pneumonia in hospital and community scenarios. A comparative study was performed from 1983 to 2005, with 425 cases of pneumonia due to being diagnosed during this time. The patients were divided into two groups based on the site of acquisition. Group 1 included 197 patients with community-acquired pneumonia (CALP), and group 2 included 123 patients with hospital-acquired pneumonia (HALP). Respiratory symptoms, gastrointestinal, neurological manifestations, and laboratory abnormalities prevailed in the community setting probably for two reasons: first, the CALP patients entered the hospital late because of the lack of specificity in initial symptomatology, allowing extrapulmonary symptoms to develop. Second, in hospitals with endemic legionellosis, the diagnosis and the onset of treatment for nosocomial pneumonia is immediate because of the high level of suspicion. This makes the extrapulmonary manifestations of infection less likely to be observed. The best way to prevent HALP is by culturing the hospital water supply, and, if colonized, Legionella tests should be used in any case of hospital-acquired pneumonia.

Citation: Pedro-Botet M, Mateu L, Sopena N, Roure S, Casas I, García-Núñez M, Rey-Joly C, Sabrià M. 2006. Hospital-and Community-Acquired L Pneumonia: Two Faces of the Same Disease?, p 22-24. In Cianciotto N, Kwaik Y, Edelstein P, Fields B, Geary D, Harrison T, Joseph C, Ratcliff R, Stout J, Swanson M (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555815660.ch04
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Anonymous. 1997. CDC guidelines focus on prevention of nosocomial pneumonia. Am. J. Health Syst. Pharm. 54: 10221025.
2. Den Boer, J. W. and, E. P. F. Yzerman. 2004. Diagnosis of Legionella infection in Legionnaires’ disease. Eur. J. Clin. Microbiol. Infect. Dis. 23: 871878.
3. Helms, C. M., J. P. Viner,, D. D. Weisenburger,, L. C. Chiu,, E. D. Renner and, W. Jonson. 1984. Sporadic Legionnaires’ disease: clinical observations on 87 nosocomial and community-acquired cases. Am. Med. J. Sci. 288: 212.
4. Pedro-Botet, M. L., M. Sabriá-Leal,, M. Haro,, C. Rubio,, G. Gimenez,, N. Sopena, and, J. Tor . 1995. Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis. Eur. Respir. J. 8: 19291933.
5. Pedro-Botet, M. L.,, M. Sabriá Leal,, N. Sopena,, J. M. Manterola,, J. Morera,, R. Blavia,, E. Padilla,, L. Matas, and, J. M. Gimeno. 1998. Role of immunosuppression in the evolution of legionnaires’ disease. Clin. Infect. Dis. 26: 1419.
6. Sabria, M., and, V. L. Yu. 2002. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet ID 2: 368373.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error